Journal Article Summary
The article discusses a unique case involving the long-term use of phosphodiesterase-5 inhibitors (PDE-5 inhibitors) in a patient with portal hypertension due to liver cirrhosis. This topic is significant because portal hypertension is a serious complication of liver cirrhosis that can lead to life-threatening conditions, such as bleeding from esophageal varices. While non-selective beta-blockers are commonly used to manage this condition, the potential for PDE-5 inhibitors to provide a long-lasting benefit has not been thoroughly explored until now.
The study focused on a 53-year-old woman with liver cirrhosis who had experienced multiple episodes of bleeding from esophageal varices. After initial testing showed that the PDE-5 inhibitor Vardenafil reduced portal pressure and increased blood flow, the patient was placed on a long-term regimen of Tadalafil. Over eight years of follow-up, the patient maintained stable portal blood flow and did not experience any further bleeding episodes from varices. The findings suggest that PDE-5 inhibitors may have a sustained positive effect on portal hypertension in patients with liver cirrhosis.
However, the study has limitations, including the fact that it is based on a single case report, which may not be generalizable to all patients with similar conditions. Additionally, while no significant side effects were noted, the long-term safety and efficacy of PDE-5 inhibitors for this use require further investigation. Patients should consult their healthcare providers before considering PDE-5 inhibitors, especially since this treatment is not yet widely accepted for managing portal hypertension. Discussing potential benefits and risks with a healthcare professional is crucial for making informed treatment decisions.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Deibert Peter, Lazaro Adhara, Stankovic Zoran, Schaffner Denise, Rössle Martin, Kreisel Wolfgang. Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up. World Journal of Gastroenterology 2018. DOI: 10.3748/wjg.v24.i3.438. PMID: 29391766. PMCID: PMC5776405.
Featured Pill Pals Product
Tadalafil 5 MG Tablets --- Generic for Cialis --- Ajanta Pharma
Tadalafil 5 MG Tablets — Generic for Cialis — Ajanta Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
